Key points are not available for this paper at this time.
KSD is a costly disease, comparable to the combined cost of prostate and bladder cancer in UK.
Geraghty et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: